MedTrace Logo

Immune Score Based Radiomics in Nasopharyngeal Carcinoma

NCT05126160 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 494

Last updated 2021-11-18

No results posted yet for this study

Summary

In nasopharyngeal carcinoma (NPC), tumor, node and metastasis (TNM) staging system is the main tool for determining treatment strategy and assessment of prognosis. However, the prognoses of patients with the same TNM stage after similar treatment vary widely. The aim of this study is to establish an immune score based radiomic staging system for NPC.

Conditions

  • Nasopharyngeal Carcinoma

Interventions

DIAGNOSTIC_TEST

Immune Score Based Radiomics

To establish an immune score based radiomic staging system for nasopharyngeal carcinoma

Sponsors & Collaborators

  • Renmin Hospital of Wuhan University

    collaborator OTHER

  • First Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER

  • Ningbo Medical Center Lihuili Hospital

    collaborator OTHER_GOV

  • Ningbo No. 1 Hospital

    collaborator OTHER

  • Zhejiang Cancer Hospital

    lead OTHER

Principal Investigators

  • Xiaozhong Chen · Department of Radiation Oncology, Zhejiang Cancer Hospital

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-05
Primary Completion
2022-10-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05126160 on ClinicalTrials.gov